Three Month Subacute Toxicity Study of Ginkgo Biloba Extract(EGb 761) in Rabbits

  • Published : 1996.06.01

Abstract

Group of 12 male and 12 female rabbits was given daily intravenous injections of different dosage of Ginkgo biloba extract(EGb 761), 7.5 mg/kg/day (low dosage group), 15 mg/kg/day (middle dosage group), or 30 mg/kg/day (high dosage group)for 3 month by ear vein according to Established Regulation of Korean National Institute of Safety Research (1994. 4. 14). Appearance, behavior, mortality, and food consumption of rabbits of treated groups were not affected during the experimental periods. No significant Ginkgo biloba extract(EGb 761)-related changes were found in urinalysis, hematology, serum chemistry, and organ weight. No histopathological lesions were seen in both control and treatment groups. Our results strongly suggest that no toxic changes should be found in rabbit treated intravenously with Ginkgo biloba extract(EGb 761)for 3 month.

Keywords

References

  1. Lancet v.1 Effects of a glnk-golide mixture (BN 52063) in antagonisting skin and platelet responses to platelet activating factor in man Chung,K.F.;Dent,G.;McCusker,M.;Guinot,P.H.;Page,C.P.;Barnes,P.J.
  2. Ginkgo biloba extract(EGb 761); pharmacological activities and clinical applications. DeFeudis,F.G.
  3. Lancet v.340 Ginkgo biloba Jos,K.;Paul,K.
  4. Arzneimittelforschung v.42 no.4 Ginkgo biloba extract in peripheral arterial diseases. Meta-analysis of controlled clinical studies Schneider,B.
  5. Pharmacopsychiatry v.28 no.4 Cognitive psychophysiology in nootropic drug research; effects of Ginkgo biloba extract on event-related potentials (P300) in age-associated memory impairment Semlitsch,H.V.;Anderer,P.;Deckerm,K.A.